World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
8749
World Ranking
4255
National Ranking
202

Stéphane Paul publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stéphane Paul sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 276 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stéphane Paul D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stéphane Paul sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stéphane Paul is affiliated with the Centre Hospitalier Universitaire de Saint-Étienne in France. Their research spans multiple fields with a strong focus on Medicine and Immunology and Microbiology. Within these broad areas, their work extensively covers subfields such as Immunology, Infectious Diseases, Genetics, Epidemiology, and Molecular Biology.

The scientist's research topics include:

  • Inflammatory Bowel Disease
  • SARS-CoV-2 and COVID-19 Research
  • Microscopic Colitis
  • Immunodeficiency and Autoimmune Disorders
  • COVID-19 Clinical Research Studies
  • Chronic Lymphocytic Leukemia Research
  • Immunotherapy and Immune Responses

Among the recent papers associated with the scientist are:

  • "Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths" (2021) published in Science Immunology
  • "A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity" (2021) published in Cellular and Molecular Immunology
  • "Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination" (2021) published in Nature
  • "COVID-19 may induce Guillain-Barré syndrome" (2020) published in Revue Neurologique
  • "The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies" (2022) published in Proceedings of the National Academy of Sciences

The scientist frequently collaborates with several co-authors, including:

  • Xavier Roblin
  • Stéphane Nancey
  • Anne-Emmanuelle Berger
  • Bruno Pozzetto
  • Pauline Veyrard

Their publications often appear in journals such as:

  • Journal of Crohn s and Colitis
  • Gastroenterology
  • Alimentary Pharmacology & Therapeutics
  • npj Vaccines
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases

    Xavier Roblin;Hubert Marotte;Melanie Rinaudo;Emilie Del Tedesco

  • A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.

    Vincent Legros;Vincent Legros;Solène Denolly;Manon Vogrig;Bertrand Boson

  • Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study.

    Stephane Paul;Emilie Del Tedesco;Hubert Marotte;Melanie Rinaudo-Gaujous

  • Gene-based vaccines and immunotherapeutics

    Margaret Liu;Bruce Acres;Jean-Marc Balloul;Nadine Bizouarne

  • New insights in mucosal vaccine development

    Vincent Pavot;Nicolas Rochereau;Christian Genin;Bernard Verrier

  • Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases

    Xavier Roblin;M Rinaudo;E Del Tedesco;J M Phelip

  • Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination.

    Bruno Pozzetto;Vincent Legros;Vincent Legros;Sophia Djebali;Véronique Barateau

  • Dectin-1 Is Essential for Reverse Transcytosis of Glycosylated SIgA-Antigen Complexes by Intestinal M Cells

    Nicolas Rochereau;Daniel Drocourt;Eric Perouzel;Vincent Pavot

  • Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis

    Anthony Lopez;Xavier Mariette;Hervé Bachelez;Alexandre Belot

  • Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting

    Alice Gutjahr;Capucine Phelip;Anne-Line Coolen;Claire Monge

  • Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

    Nicolas Williet;Gilles Boschetti;Marion Fovet;Thomas Di Bernado

  • Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab

    B. Ungar;U. Kopylov;T. Engel;M. Yavzori

  • Receptor and nonreceptor protein tyrosine phosphatases in the nervous system.

    S. Paul;P. J. Lombroso

  • Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

    Xavier Roblin;Nicolas Williet;Gilles Boschetti;Jean-Marc Phelip

  • Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial

    X. Roblin;G. Boschetti;N. Williet;Stéphane Nancey

  • Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study

    W. Yacoub;N. Williet;L. Pouillon;T. Di-Bernado

  • Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.

    Vincent Pavot;Morgane Berthet;Julien Rességuier;Sophie Legaz

  • Combination of C-reactive protein, infliximab trough levels and stable but not transient antibodies to infliximab are associated with loss of response to infliximab in inflammatory bowel disease

    X. Roblin;H. Marotte;M. Leclerc;E. Del Tedesco

  • Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells.

    Charlotte Primard;Nicolas Rochereau;Elsa Luciani;Christian Genin

  • Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis.

    Amelie Carla Moreau;Stephane Paul;Emilie Del Tedesco;Melanie Rinaudo-Gaujous

  • Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.

    Jonathan Lopez;Marine Mommert;William Mouton;William Mouton;Andrés Pizzorno

Frequent Co-Authors

Bernard Verrier
Bernard Verrier Claude Bernard University Lyon 1
Laurent Peyrin-Biroulet
Laurent Peyrin-Biroulet University of Lorraine
Bruno Pozzetto
Bruno Pozzetto École Normale Supérieure de Lyon
Blaise Corthésy
Blaise Corthésy University Hospital of Lausanne
Nicole M. Thielens
Nicole M. Thielens Grenoble Alpes University
Rami Eliakim
Rami Eliakim Tel Aviv University
Frédéric Batteux
Frédéric Batteux Université Paris Cité
Xavier Hébuterne
Xavier Hébuterne Université Côte d'Azur
Jean-Yves Bonnefoy
Jean-Yves Bonnefoy Salto Therapeutics
Bruno Lina
Bruno Lina Claude Bernard University Lyon 1

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to various specialized healthcare careers, including nurse practitioner roles focused on mental health. Many students explore online nursing programs as a flexible path to advance their knowledge and careers. For those seeking less intensive coursework, exploring the easiest nurse practitioner program options can be a strategic starting point.

For professionals interested in psychiatric nursing, the top online pmhnp programs offer not only quality education but also strong clinical placement support, which is crucial for hands-on experience. Balancing cost and quality is also important, and resources listing the cheapest psych np programs can help prospective students make informed decisions about their investments.

Career prospects and earnings vary widely depending on specialization and location. Understanding how much do dnp nurses make in different states can provide valuable insights for graduates evaluating potential job markets and planning their career paths.

Best Scientists Citing Stéphane Paul

Trending Scientists

Recently Published Articles